1-1 of 1
Rene Kerstens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-Risk Myelodysplastic Syndrome (MDS): First Results of International Phase 2 Study with Oral Farnesyltransferase Inhibitor R115777 (ZARNESTRA TM ).

Razelle Kurzrock, MD, Pierre Fenaux, MD, Azra Raza, MD, Ghulam Mufti, MD, Carlo Aul, MD, Ulrich Germing, MD, Rene Kerstens, MD, Peter DePorre, MD
Journal: Blood
Blood (2004) 104 (11): 68.
https://doi.org/10.1182/blood.V104.11.68.68
Published: 2004